Publications - IR Sant Pau

Search

24/02/2023 Clinical outcomes in patients with atrial fibrillation treated with DOACs in a specialized anticoagulation center: Critical appraisal of real-world data

Moret, C, Acosta-Isaac, R, Mojal, S, Corrochano, M, Jimenez, B, Plaza, M, Souto, JC. Clinical outcomes in patients with atrial fibrillation treated with DOACs in a specialized anticoagulation center: Critical appraisal of real-world data. PLoS One. 2023; 18(2)DOI:10.1371/journal.pone.0279297. PMID:36827286. IF:2.900(Q1/3D).

01/01/2023 Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning

Muñoz A.J., Souto J.C., Lecumberri R., Obispo B., Sanchez A., Aparicio J., Aguayo C., Gutierrez D., Palomo A.G., Fanjul V., del Rio-Bermudez C., Viñuela-Benéitez M.C., Hernández-Presa M.Á.. Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning. THROMBOSIS RESEARCH. 2023; 228DOI:10.1016/j.thromres.2023.06.015. PMID:37348318. IF:3.700(Q1/3D).

01/08/2022 Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products

Megias-Vericat, JE, Boix, SB, Moreno, RB, Mingot-Castellano, ME, Lopez, MR, Hirnyk, MC, Arranz, JM, Villas, JMC, Guaita, SH, Meda, MM, Jaime, FL, Albo-Lopez, C, Palomero-Massanet, A, Seto, NV, Lecinena, IL, Haro, ARC, Andres, JLP. Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products. THROMBOSIS RESEARCH. 2022; 216DOI:10.1016/j.thromres.2022.06.001. PMID:35696967. IF:7.500(Q1/2D).

01/05/2022 Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH-SETH

Gonzalez-Porras, JR, Mateo, J, Gonzalez-Calle, V, Marco, P, Garcia-Gutierrez, V, Reverter, JC, Lecumberri, R. Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH-SETH. Clinical & Translational Oncology. 2022; 24(5)DOI:10.1007/s12094-021-02735-1. PMID:34850351. IF:3.400(Q3/6D).

01/05/2022 Superwarfarin poisoning: challenges still remain

Gil, AD, Suarez, GMG, Puig, CM, Ganoza, AH. Superwarfarin poisoning: challenges still remain. Bmj Case Reports. 2022; 15(5)DOI:10.1136/bcr-2021-248385. PMID:35584857. IF:(Q/D).

01/02/2022 Clinical Efficacy and Safety of Fanhdi(R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study

Jimenez-Yuste, V, Alvarez-Roman, MT, Bravo, AP, Galmes, BJ, Hernandez, MDN, Hidalgo, OB, Alonso, CM, Gonzalez, NFP, Coll, J, Nunez, R, Carrasco, M, Candel, FG, Gonzalez-Porras, JR, Garcia, CH, Castro, MJV, Mir, R. Clinical Efficacy and Safety of Fanhdi(R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. 2022; 28DOI:10.1177/10760296221074348. PMID:35108125. IF:2.900(Q3/6D).

26/01/2022 The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis

Soto, I, Mateo, J, Garcia-Diego, DA, Gil, B, Ruiz-Beato, E, Ivanova, Y, Lorenzo, TM, Maravilla-Herrera, P, Hidalgo-Vega, A, Merino, M. The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis. BMC HEALTH SERVICES RESEARCH. 2022; 22(1)DOI:10.1186/s12913-021-07447-4. PMID:35081958. IF:2.800(Q3/6D).

21/01/2022 Current status of diagnosis and treatment of heparin-induced thrombocytopenia (HIT)

Paramo, JA, Lozano, ML, Gonzaalez-Porras, JR, Mateo, J. Current status of diagnosis and treatment of heparin-induced thrombocytopenia (HIT). MEDICINA CLINICA. 2022; 158(2)DOI:10.1016/j.medcli.2021.05.020. PMID:34311973. IF:3.900(Q2/4D).

01/01/2022 Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants

Corrochano M., Acosta-Isaac R., Plaza M., Muñoz R., Mojal S., Moret C., Souto J.C.. Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants. PLoS One. 2022; 17(12)DOI:10.1371/journal.pone.0278693. PMID:36490245. IF:3.700(Q2/4D).

01/11/2021 Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES project

Perez-Rodriguez, A, Batlle, J, Pinto, JC, Corrales, I, Borras, N, Garcia-Martinez, I, Cid, AR, Bonanad, S, Parra, R, Mingot-Castellano, ME, Navarro, N, Altisent, C, Perez-Montes, R, Moreto, A, Herrero, S, Soto, I, Mosteirin, NF, Jimenez-Yuste, V, Jacob, AD, Fontanes, E, Mateo, J, Quismondo, NC, Batlle, F, Vidal, F, Lopez-Fernandez, MF. Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES project. HAEMOPHILIA. 2021; 27(6)DOI:10.1111/hae.14405. PMID:34494337. IF:4.268(Q2/5D).

12/10/2021 Management of acquired hemophilia A: results from the Spanish registry

Mingot-Castellano, ME, Pardos-Gea, J, Haya, S, Bastida-Bermejo, JM, Tassies, D, Marco-Rico, A, Nunez, R, Garcia-Candel, F, De Mora, MCFS, Soto, I, Alvarez-Roman, MT, Asenjo, S, Carrasco, M, Lluch-Garcia, R, Martin-Antoran, JM, Rodriguez-Alen, A, Rosello, E, Torres-Minana, L, Marcellini-Antonio, S, Moreto-Quinana, A, Rodriguez-Garcia, JA, Aguinaco-Culebras, R, Alonso-Escobar, N, Cervero-Santiago, C, Fernandez-Mosteirin, N, Martinez-Badas, MP, Perez-Sanchez, M, Perez-Montes, R, Rodriguez-Gonzalez, R, Uribe-Barrientos, M, Caparros-Miranda, IS, Iglesias-Fernandez, M, Baena, A, Rodriguez-Lopez, M, Sebrango-Sandia, A, Vazquez-Fernandez, I, Marco, P. Management of acquired hemophilia A: results from the Spanish registry. Blood Advances. 2021; 5(19)DOI:10.1182/bloodadvances.2021004626. PMID:34521101. IF:7.642(Q1/3D).

02/09/2021 Expert opinion paper on the treatment of hemophilia B with albutrepenonacog alfa

Roman, MTA, Benitez, O, Canaro, MI, Fernandez, MFL, Jaime, FLJ, Arranz, JM, Nunez, R, Lopez, MR, Aisa, CS, Jimenez-Yuste, V. Expert opinion paper on the treatment of hemophilia B with albutrepenonacog alfa. EXPERT OPINION ON BIOLOGICAL THERAPY. 2021; 21(9)DOI:10.1080/14712598.2021.1932811. PMID:34225551. IF:5.589(Q1/3D).

01/07/2021 Covid-19, hypercoagulability and risk of mortality in schizophrenia

Garcia-Ribera, C, Carrasco, M, Ruiz-Ripoll, A. Covid-19, hypercoagulability and risk of mortality in schizophrenia. ACTAS ESPANOLAS DE PSIQUIATRIA. 2021; 49(4)DOI:. PMID:34195973. IF:1.667(Q4/9D).

01/10/2025 Consensus on the Management of the Clinical Challenges of Venous Thromboembolism in Special Situations

Marzo, C, Solanich, T, Tassies, D, Pina, E, Rebollo, MA, Gallardo, E, Serradell, S, Merino, M, Carrasco, M, Tugues, A. Consensus on the Management of the Clinical Challenges of Venous Thromboembolism in Special Situations. THROMBOSIS AND HAEMOSTASIS. 2025; 125(10)DOI:10.1055/a-2595-1811. PMID:40359988. IF:4.300(Q1/2D).

09/05/2025 Patient-Centred Management of Well-Controlled Haemophilia: Obtaining Opinions and Definitions Through a Delphi Consensus

Berrueco, R, Soto, I, Bastida, JM, Villas, JMC, de Cos, C, Haya, S, García, FS, Arranz, JM. Patient-Centred Management of Well-Controlled Haemophilia: Obtaining Opinions and Definitions Through a Delphi Consensus. Journal of Clinical Medicine. 2025; 14(10)DOI:10.3390/jcm14103300. PMID:40429300. IF:2.900(Q1/2D).

29/01/2025 Identification of strengths and weaknesses of the healthcare system for persons living with rare diseases in Catalonia (Spain), and recommendations to improve its comprehensive attention: the "acERca las enfermedades raras" project

Hernández-Rodríguez, J, Martínez-Valle, F, Acebes, X, Alerany, C, Antón, J, Calvo, G, Corral, M, Cruz, J, Mangues-Bafalluy, MA, Mateo, J, Rivera, J, Salazar, A, Francisco, R, Mallol, C, Reig-Viader, R, Tigri-Santiña, A, Ricart, A, Palau, F. Identification of strengths and weaknesses of the healthcare system for persons living with rare diseases in Catalonia (Spain), and recommendations to improve its comprehensive attention: the "acERca las enfermedades raras" project. Orphanet Journal of Rare Diseases. 2025; 20(1)DOI:10.1186/s13023-024-03518-x. PMID:39875900. IF:3.500(Q2/4D).

01/01/2025 Safety and Efficacy of the Use of pdVWF/FVIII-C in Patients with von Willebrand Disease: A Prospective, Observational, Post-Authorization Study

Hidalgo, OB, Alonso, CM, Jaime, FJL, Carrasco, M, Hernández, MDN, Afonso, N, Lei, A, Whyms, D, Hanna, K, Aragonés, ME, Torres, M, Oliveras, J. Safety and Efficacy of the Use of pdVWF/FVIII-C in Patients with von Willebrand Disease: A Prospective, Observational, Post-Authorization Study. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. 2025; 31DOI:10.1177/10760296251327593. PMID:40079811. IF:2.000(Q3/6D).

01/01/2025 Acquired FXIII Deficiency Secondary to a Myelodysplastic Syndrome

Vilalta, N, Oñate, G, Triquell, M, Carrasco, M, Mateo, J. Acquired FXIII Deficiency Secondary to a Myelodysplastic Syndrome. HAEMOPHILIA. 2025; 31DOI:. PMID:. IF:3.000(Q2/4D).

01/01/2025 Prospective View of Emicizumab Treatment According Thrombin Generation Time

Vilalta, N, Triquell, M, Llobet, D, Simón, M, Cerdà, N, Carrasco, M, Mateo, J. Prospective View of Emicizumab Treatment According Thrombin Generation Time. HAEMOPHILIA. 2025; 31DOI:. PMID:. IF:3.000(Q2/4D).

02/12/2024 Adult maxillary expansion: CBCT evaluation of skeletal changes and determining an efficiency factor between force-controlled polycyclic slow activation and continuous rapid activation for mini-screw-assisted palatal expansion - MASPE vs. MARPE

Walter, A, Winsauer, H, Crespo, E, Walter, D, Winsauer, C, Schwärzler, A, Mojal, S, Arcos, I, Puigdollers, A. Adult maxillary expansion: CBCT evaluation of skeletal changes and determining an efficiency factor between force-controlled polycyclic slow activation and continuous rapid activation for mini-screw-assisted palatal expansion - MASPE vs. MARPE. Head & Face Medicine. 2024; 20(1)DOI:10.1186/s13005-024-00474-6. PMID:39617918. IF:2.600(Q2/3D).

07/04/2022 Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure

Perez, PC, Gonzalez-Juanatey, JR, Nuche, J, Matute-Blanco, L, Serrano, I, Selles, MM, Garcia, RV, Dolz, LM, Gomez-Bueno, M, Figal, DP, Crespo-Leiro, MG, Garcia-Osuna, A, Ordonez-Llanos, J, Cuscullola, JC, Guerra, JM, Delgado, JF. Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure. Frontiers in Cardiovascular Medicine. 2022; 9DOI:10.3389/fcvm.2022.861651. PMID:35463785. IF:3.600(Q2/5D).

22/10/2021 A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure

Alvarez-Garcia, J, Garcia-Osuna, A, Vives-Borras, M, Ferrero-Gregori, A, Martinez-Selles, M, Vazquez, R, Gonzalez-Juanatey, JR, Rivera, M, Segovia, J, Pascual-Figal, D, Bover, R, Bascompte, R, Delgado, J, Sepulveda, AG, Bardaji, A, Perez-Villa, F, Zamorano, JL, Crespo-Leiro, M, Sanchez, PL, Ordonez-Llanos, J, Cinca, J. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure. Frontiers in Physiology. 2021; 12DOI:10.3389/fphys.2021.708890. PMID:34744758. IF:4.755(Q1/3D).

01/08/2021 Do All Integrase Strand Transfer Inhibitors Have the Same Lipid Profile? Review of Randomised Controlled Trials in Naive and Switch Scenarios in HIV-Infected Patients

Saumoy, M, Sanchez-Quesada, JL, Ordonez-Llanos, J, Podzamczer, D. Do All Integrase Strand Transfer Inhibitors Have the Same Lipid Profile? Review of Randomised Controlled Trials in Naive and Switch Scenarios in HIV-Infected Patients. Journal of Clinical Medicine. 2021; 10(16)DOI:10.3390/jcm10163456. PMID:34441755. IF:4.964(Q2/4D).

01/08/2021 Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations

Saumoy, M, Di Yacovo, S, Perez, S, Sanchez-Quesada, JL, Valdivielso, JM, Subirana, I, Imaz, A, Tiraboschi, JM, Garcia, B, Ordonez-Llanos, J, Benitez, S, Podzamczer, D, Grau, M. Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations. HIV MEDICINE. 2021; 22(7)DOI:10.1111/hiv.13093. PMID:33817938. IF:3.094(Q3/8D).

06/07/2021 Cardiac Biomarker Kinetics and Their Association With Magnetic Resonance Measures of Cardiomyocyte Integrity Following a Marathon Run: Implications for Postexercise Biomarker Testing

Aengevaeren, VL, van Kimmenade, RRJ, Ordonez-Llanos, J, Garcia-Osuna, A, Kaier, TE, Marber, M, Froeling, M, van den Berg-Faay, S, Hooijmans, MT, Monte, JR, Hopman, MTE, Strijkers, GJ, Nederveen, AJ, Bakermans, AJ, Eijsvogels, TMH. Cardiac Biomarker Kinetics and Their Association With Magnetic Resonance Measures of Cardiomyocyte Integrity Following a Marathon Run: Implications for Postexercise Biomarker Testing. Journal of the American Heart Association. 2021; 10(13)DOI:10.1161/JAHA.120.020039. PMID:34180243. IF:6.107(Q2/3D).

24/10/2025 LDL atherogenicity determined by size, density, oxidation, apolipoprotein(a), and electronegativity: an updated review

Akyol, O, Chiang, HH, Burns, AR, Yang, CY, Woodside, DG, Sawamura, T, Sánchez-Quesada, JL, Gotto, AM, Chen, CH. LDL atherogenicity determined by size, density, oxidation, apolipoprotein(a), and electronegativity: an updated review. Frontiers in Cardiovascular Medicine. 2025; 12DOI:10.3389/fcvm.2025.1649759. PMID:41210345. IF:2.900(Q2/4D).

01/06/2025 Biomarkers of inflammation and coagulation predict non-AIDS-defining events in a prospective cohort of virologically suppressed people living with HIV

Saumoy, M, Fernandez, A, Tiraboschi, J, Peñafiel, J, Sánchez-Quesada, JL, Vega, J, García, B, Soriano, I, Podzamczer, D, Imaz, A. Biomarkers of inflammation and coagulation predict non-AIDS-defining events in a prospective cohort of virologically suppressed people living with HIV. HIV MEDICINE. 2025; 26(6)DOI:10.1111/hiv.70017. PMID:40130659. IF:3.200(Q2/4D).

01/11/2024 A new perspective on the regulatory role of miRNAS. Cross-kingdom regulation

Sánchez-Quesada, JL. A new perspective on the regulatory role of miRNAS. Cross-kingdom regulation. Clinica E Investigacion En Arteriosclerosis. 2024; 36(6)DOI:10.1016/j.arteri.2024.10.003. PMID:39542529. IF:(Q/D).

04/08/2023 Non-invasive electromechanical assessment during atrial fibrillation identifies underlying atrial myopathy alterations with early prognostic value

Enríquez-Vázquez D., Quintanilla J.G., García-Escolano A., Couselo-Seijas M., Simón-Chica A., Lee P., Alfonso-Almazán J.M., Mahía P., Redondo-Rodríguez A., Modrego J., Ortega-Hernández A., Marcos-Alberca P., Magni R., Calvo E., Gómez-Gordo R., Yan P., La Rosa G., Bustamante-Madrión J., Pérez-García C.N., Martín-Sánchez F.J., Calvo D., de la Hera J.M., García-Torrent M.J., García-Osuna Á., Ordonez-Llanos J., Vázquez J., Pérez-Villacastín J., Pérez-Castellano N., Loew L.M., Sánchez-González J., Gómez-Garre D., Filgueiras-Rama D.. Non-invasive electromechanical assessment during atrial fibrillation identifies underlying atrial myopathy alterations with early prognostic value. Nature Communications. 2023; 14(1)DOI:10.1038/s41467-023-40196-y. PMID:37542075. IF:14.700(Q1/1D).

01/07/2023 Special Issue: New Insight into the Molecular Role of Lipids and Lipoproteins in Vascular Diseases

Benitez, S, Sanchez-Quesada, JL. Special Issue: New Insight into the Molecular Role of Lipids and Lipoproteins in Vascular Diseases. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(13)DOI:10.3390/ijms241310659. PMID:37445837. IF:4.900(Q1/3D).

01/12/2021 ICD shock below the detection rate therapy zone-When appropriate is inadequate

Garcia-Hernando, V, Mendez-Zurita, F, Rodriguez-Font, E, Alonso-Martin, C, Guerra-Ramos, JM, Campos-Garcia, B, Moreno-Weidmann, Z, Benedicto, AM, Vinolas, X. ICD shock below the detection rate therapy zone-When appropriate is inadequate. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY. 2021; 32(12)DOI:10.1111/jce.15241. PMID:34532919. IF:2.942(Q3/6D).

01/10/2021 Relationship between multimorbidity and outcomes in atrial fibrillation

Proietti, M, Esteve-Pastor, MA, Rivera-Caravaca, JM, Roldan, V, Rabadan, IR, Muniz, J, Cequier, A, Bertomeu-Martinez, V, Badimon, L, Anguita, M, Lip, GYH, Marin, F, FANTASIIA Study Investigators. Relationship between multimorbidity and outcomes in atrial fibrillation. EXPERIMENTAL GERONTOLOGY. 2021; 153DOI:10.1016/j.exger.2021.111482. PMID:34303775. IF:4.253(Q2/5D).

01/10/2022 Impact of Diabetes Mellitus on the Potential of Autologous Stem Cells and Stem Cell-Derived Microvesicles to Repair the Ischemic Heart

Vilahur, G, Nguyen, PH, Badimon, L. Impact of Diabetes Mellitus on the Potential of Autologous Stem Cells and Stem Cell-Derived Microvesicles to Repair the Ischemic Heart. CARDIOVASCULAR DRUGS AND THERAPY. 2022; 36(5)DOI:10.1007/s10557-021-07208-9. PMID:34251593. IF:3.400(Q2/5D).

01/07/2022 Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium

Gorog, DA, Storey, RF, Gurbel, PA, Tantry, US, Berger, JS, Chan, MY, Duerschmied, D, Smyth, SS, Parker, WAE, Ajjan, RA, Vilahur, G, Badimon, L, ten Berg, JM, ten Cate, H, Peyvandi, F, Wang, TT, Becker, RC. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nature Reviews Cardiology. 2022; 19(7)DOI:10.1038/s41569-021-00665-7. PMID:35027697. IF:49.600(Q1/1D).

01/12/2021 Dyslipidemia and aortic valve disease

Mata, P, Alonso, R, de Isla, LP, Badimon, L. Dyslipidemia and aortic valve disease. CURRENT OPINION IN LIPIDOLOGY. 2021; 32(6)DOI:10.1097/MOL.0000000000000794. PMID:34629429. IF:4.616(Q2/4D).

01/12/2021 One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction

Chiva-Blanch, G, Bratseth, V, Laake, K, Arnesen, H, Solheim, S, Schmidt, EB, Badimon, L, Seljeflot, I. One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction. CLINICAL NUTRITION. 2021; 40(12)DOI:10.1016/j.clnu.2021.10.007. PMID:34742136. IF:7.643(Q1/2D).

01/08/2021 PCSK9 and LRP5 in macrophage lipid internalization and inflammation

Badimon, L, Luquero, A, Crespo, J, Pena, E, Borrell-Pages, M. PCSK9 and LRP5 in macrophage lipid internalization and inflammation. CARDIOVASCULAR RESEARCH. 2021; 117(9)DOI:10.1093/cvr/cvaa254. PMID:32991689. IF:14.239(Q1/1D).

01/08/2021 The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis

Badimon, L, Vilahur, G, Rocca, B, Patrono, C. The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis. CARDIOVASCULAR RESEARCH. 2021; 117(9)DOI:10.1093/cvr/cvab003. PMID:33484117. IF:14.239(Q1/1D).

01/08/2021 Extracellular vesicles in atherothrombosis and cardiovascular disease: Friends and foes

Giro, O, Jimenez, A, Pane, A, Badimon, L, Ortega, E, Chiva-Blanch, G. Extracellular vesicles in atherothrombosis and cardiovascular disease: Friends and foes. ATHEROSCLEROSIS. 2021; 330DOI:10.1016/j.atherosclerosis.2021.07.002. PMID:34256307. IF:6.851(Q1/2D).

01/08/2021 Smoking and sex differences in first manifestation of cardiovascular disease

Vasiljevic, Z, Scarpone, M, Bergami, M, Yoon, J, van der Schaar, M, Krljanac, G, Asanin, M, Davidovic, G, Simovic, S, Manfrini, O, Mickovski-Katalina, N, Badimon, L, Cenko, E, Bugiardini, R. Smoking and sex differences in first manifestation of cardiovascular disease. ATHEROSCLEROSIS. 2021; 330DOI:10.1016/j.atherosclerosis.2021.06.909. PMID:34233252. IF:6.851(Q1/2D).